Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 11, 2002, Pages 5229-5234

  Hapangama, Dharani K ^a   Critchley, Hilary O D ^a   Henderson, Teresa A ^a   Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE 2; MIFEPRISTONE;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; ENDOMETRIUM BIOPSY; FEMALE; HORMONAL REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUTEAL PHASE; LUTEOLYSIS; MEDIATOR RELEASE; MENSTRUATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; STROMA CELL; VAGINA BLEEDING;

ADULT; CYCLOOXYGENASE 2; ENDOMETRIUM; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; ISOENZYMES; KINETICS; LUTEAL PHASE; LUTEINIZING HORMONE; MEMBRANE PROTEINS; MIFEPRISTONE; PROGESTERONE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; UTERINE HEMORRHAGE;

EID: 0036845494     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020429     Document Type: Article

References (41)

1. Corner GW, Allen WM 1929 Physiology of the corpus luteum-II: Production of a special uterine reaction (progestational proliferation) by extracts of the corpus luteum. Am J Physiol 88:326-329
2. Critchley HOD, Kelly RW, Brenner RM, Baird DT 2001 The endocrinology of menstruation - A role for the immune system. Clin Endocrinol 55:701-710
3. Baird DT, Cameron ST, Critchley HOD, Drudy TA, Howe A, Jones RL, Lea RG, Kelly RW 1996 Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol 70:15-17
4. Spitz IM, Bardin CW 1993 Clinical pharmacology of RU 486 - An antiprogestin and antiglucocorticoid. Contraception 48:403-44
5. Schaison GM, Lestrat N, Reinberg A, Baulieu EE 1985 Effects of the anti-progesterone steroid RU 486 during midluteal phase in normal women. J Clin Endocrinol Metab 61:484-489
6. Shoupe D, Mishell Jr DR, Lahteenmaki P, Heikinheimo O, Birgerson L, Madkour H, Spitz IM 1987 Effects of the antiprogesterone RU 486 in normal women. I single dose administration in the midluteal phase. Am J Obstet Gynecol 157:1415-1420
7. Johannisson E, Oberholzer M, Swahn M-L, Bygdeman M 1988 Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception 39:103-117
8. Swahn ML, Bygdeman M, Xing S, Cekan S, Masironi B, Johannisson E 1990 The effects of RU 486 administered during the early-luteal phase on bleeding pattern hormonal parameters' and endometrium. Hum Reprod 5:402-408
9. Gemzell-Danielsson K, Svalander P, Swahn M-L, Johannisson E, Bygdeman M 1994 Effects of a single post ovulatory dose of RU 486 on endometrial maturation in the implantation phase. Hum Reprod 9:2398-2404
10. Cameron ST, Critchley HOD, Buckley CH, Chard T, Baird DT 1996 The effects of post ovulatory administration of onapristone on the development of a secretory endometrium. Hum Reprod 11:40-49
11. Cameron ST, Critchley HOD, Buckley CH, Kelly RW, Baird DT 1997 Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil Steril 67:1046-1053
12. Casey ML, Hemsell DL, Johnston JM, MacDonald PC 1980 NAD-dependent 15-hydroxyprostaglandin dehydrogenase activity in human endometrium. Prostaglandins 19:115-122
13. Greenland KJ, Jantke I, Jennatschke S, Bracken KE, Vinson C, Gellersen B 2000 The human NAD+ dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Endocrinology 141:581-597
14. Wang H, Critchley HOD, Kelly RW, Shen D, Baird DT 1998 Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4:407-412
15. Croxatto HB, Salvatierra AM, Croxatto HD, Fuentealba B 1993 Effects of continuous treatment with low-dose mifepristone throughout one menstrual cycle. Hum Reprod 8:201-207
16. Spitz IM, Croxatto HB, Robbins A 1996 Antiprogestins: Mechanism of action and contraceptive potential. Annu Rev Pharmacol Toxicol 36:47-81
17. Gemzell-Danielsson K, Swahn M-L, Westlund P, Bygdeman M 1997 Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum Reprod 12:124-131
18. Swahn M-L, Johannisson E, Daniore V, de la Torre B, Bygdeman M 1988 The effect of RU 486 administration during the proliferative and secretory phase of the cycle on the bleeding pattern hormonal parameters and endometrium. Hum Reprod 3:915-921
19. Baird DT 2000 Mode of action of medical abortion. J Am Med Womens Assoc 55:121-125
20. Milne SA, Perchick GB, Boddy SC, Jabbour HN 2001 Expression, localisation, and signalling of PGE2 and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. J Clin Endocrinol Metab 86:4453-4459
21. Jones RL, Kelly RW, Critchley HOD 1997 Chemokines and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 12:1300-1306
22. Bonney RC, Franks S 1987 Modulation of phospholipase A2 activity in human endometrium and amniotic membranes by steroid hormones. J Steroid Biochem 26:467-472
23. Kelly RW, Healy DL, Cameron MJ, Cameron IT, Baird DT 1986 The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells. J Clin Endocrinol Metab 62:1116-1123
24. Lockwood CJ, Krikun G, Hausknecht VA, Papp C, Schatz F 1998 Matrix metalloproteinase inhibitor expression in endometrial stroma cells during progestin-initiated decidualisation and menstruation related progestin withdrawal. Endocrinology 139:4607-4613
25. Smith SK, Abel MH, Baird DT 1984 Effects of 17 beta-estradiol and progesterone on the levels of prostaglandins F2 alpha and E in human endometrium. Prostaglandms 27:591-597
26. Abel M, Baird DT 1980 The effect of 17β-estradiol and progesterone on prostaglandin production by human endometrium maintained in organ culture Endocrinology 106:1599-1606
27. Smith SK, Kelly RW 1987 The effect of the antiprogestin RU 486 and ZK 98734 on the synthesis and metabolism of prostaglandins F2 alpha and E2 in separated cells from early human deciduas. J Clin Endocrinol Metab 65:527-534
28. Kelly RW, Smith SK 1987 Progesterone and antiprogestins, a comparison of their effect on prostaglandin production by human secretory phase endometrium and decidua. Prostaglandins Leukot Med 29:181-186
29. Maathuis JB, Kelly RW 1978 Concentrations of prostaglandins F2 alpha and E2 in the endometcium throughout the human menstrual cycle, after the administration of clomiphene or an estrogen-progestin pill and in the early pregnancy. J Endocrinol 77:361-371
30. Critchley HOD, Jones RL, Lea RG, Drudy TA, Kelly RW, Williams ARW, Baird DT 1999 Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab 84: 240-248
31. Norman JE, Wu XW, Kelly RW, Glasier AF, McNeilly AS, Baird DT 1991 Effects of mifepristone in vivo decidual prostaglandin synthesis and metabolism. Contraception 44:89-98
32. Gemzell-Danielsson K, Swahn M-L, Bygdeman M 1990 Regulation of non-pregnant human uterine contractility. Effect of antihormones. Contraception 42:323-335
33. Gemzell-Danielsson K, Hamberg M 1994 The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (Naproxen) on uterine fluid PGF2α concentrations. Hum Reprod. 9:1626-1630
34. Cheng L, Kelly RW, Thong KJ, Hume R, Baird DT 1993 The effects of mifepristone (RU 486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy. Hum Reprod 8:705-709
35. Marions L, Danielsson KG 1999 Expression of cyclo-oxygenase in human endometrium during the implantation period. Mol Hum Reprod 5:961-965
36. Lumsden MA, Brown A, Baird DT 1984 Prostaglandin production from homogenates of separated glandular epithelium and stroma from human endometrium. Prostaglandins 28:485-496
37. Smith SK, Kelly RW 1988 The release of PGF2α and PGE2 from separated cells of human endometrium and deciduas. Prostaglandins Leukot Essent Fatty Acids 77:361-371
38. Berthois Y, Brux JD, Salat-Baroux J, Kopp F, Cornet D, Martin PM 1991 A multiparametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone. Fertil Steril 55:547-554
39. Maentausta O, Svalander P, Gemzell-Danielsson K, Bygdeman M, Vihko R 1993 The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17β-hydroxysteroid dehydrogenase and progestin and estrogen receptor during the luteal phase of the menstrual cycle; an immunohistochemical study. J Clin Endocrinol Metab 77:913-918
40. Burton KA, Hillier SG, Habib FK, Mason JI, Critchley HOD, Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HO, Baird DT, Brenner RM 2001 Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 86:2668-2679
41. Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HOD, Baird DT, Brenner RM 2001 Progesterone antagonists increase the androgen receptor expression in the rhesus macaque in human endometrium. J Clin Endocrinol Metab 86:2668-2679